Switching to DTG/3TC Is non-inferior to continuing current antiretroviral regimen at week 48: SALSA subgroup analyses

Category Primary study
ConferenceInfection and Chemotherapy
Year 2022
This article has no abstract
Epistemonikos ID: 40c2c6e372ab3725968299ba43732b8480920c49
First added on: Apr 30, 2026